Information  X 
Enter a valid email address

SAGA Plc (SAGA)

  Print      Mail a friend

Thursday 04 April, 2019

SAGA Plc

Committee membership changes

RNS Number : 0653V
SAGA PLC
04 April 2019
 

4 April 2019

SAGA PLC

Committee Appointments

Pursuant to Listing Rule LR.9.6.11, Saga plc ("the Company") announces that the following independent Non-Executive Directors have been appointed as members of the following committees:

Gareth Hoskin has been appointed as a member of the Audit Committee with effect from 4 April 2019.

The Audit Committee is now constituted as follows: Ray King (Chair), Gareth Hoskin,  Orna NiChionna and Gareth Williams  (all independent Non-Executive Directors of Saga plc).

Julie Hopes and Gareth Hoskin have been appointed as members of the Risk Committee with effect from 4 April 2019.

The Risk Committee is now constituted as follows: Orna NiChionna (Chair), Julie Hopes, Gareth Hoskin, Ray King and Gareth Williams  (all independent Non-Executive Directors of Saga plc).

Eva Eisenschimmel and Julie Hopes have been appointed as members of the Remuneration Committee with effect from 4 April 2019.

The Remuneration Committee is now constituted as follows: Gareth Williams (Chair), Eva Eisenschimmel, Julie Hopes, Orna NiChionna, Ray King  (all independent Non-Executive Directors of Saga plc).

Eva Eisenschimmel has been appointed as a member of the Nomination Committee with effect from 4 April 2019.

The Nomination Committee is now constituted as follows: Patrick O' Sullivan (Chair), Eva Eisenschimmel, Orna NiChionna, Ray King and Gareth Williams  (all independent Non-Executive Directors of Saga plc).

 

Enquiries

 

Saga plc

Vicki Haynes, Company Secretary                                                                                             Tel: 01303 771199

Enbrook Park

Sandgate

Folkestone

Kent

CT20 3SE

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BOABCGDSBDGBGCX

a d v e r t i s e m e n t